期刊文献+

血小板型磷脂酶A_2与肿瘤的关系 被引量:6

The relationship of platelet phospholipase A, and tumor
下载PDF
导出
摘要 磷脂酶A2是一类分布广泛的酶家族,它们与许多重要的生理和病理过程相关联,而其中一种小分子的,被称为血小板型磷脂酶A2的酶与肿瘤有密切的关系。本文就其研究的状况进行综述。 Phospholipase A2(PLA2) is an enzyme family which widely distributed in nature. It is related to many important function in physiology and pathology. Among the enzymes, a small molecule PLA2 (platelet PLA2) is closely related to tumor. The study of platelet PLA2 and tumor is reviewed.
出处 《中国癌症杂志》 CAS CSCD 2002年第6期555-558,共4页 China Oncology
基金 广西自然科学基金资助项目(9920012) 国家人事部留学回国人员科技资助项目
关键词 血小板型磷脂酶A2 肿瘤抑制基因 肿瘤 platelet PLA2 tumor suppression gene tumor
  • 相关文献

参考文献16

  • 1Dennis EA. Diversity of grouptypes,regulation,and function of phospholipase A2 [ J ]. J Biol Chem, 1994,269 ( 18 ):13057-13060
  • 2Papanikolaou A, Wang QS, Mulherkar R, et al. Expression analysis of the group Ⅱ Asecretory phospholipase A(2) in mice with differential susceptibility toazoxymethane-induced colon tumorigenesis[ J]. Carcinogenesis,2000,21 (2): 133-138.
  • 3Cormier RT, Bilger A, Lillich AJ, et al. The Moml AKR intestinal tumor resistanceregion consists of Pla2g2a and a locus distal to D4Mit64[J]. Oncogen,2000,19(28):3182-3192.
  • 4Graff JR, Konicek BW, Deddens JA,et al. Expression of group Ⅱ a secretoryphospholipase A2 increases with prostate tumor grade [ J ]. Clin Cancer Res,2001,7 ( 12 ):3857-3861.
  • 5MacPhee M, Chepenlk KP, Liddell RA, et al. The secretory phospholipase A2 gene is acandidate for the Moml locus, a major modifier of APCMin-induced intestinal neoplasia [J]. Cell,1995,81 (6) :957-966.
  • 6Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC[J].Hum Mol Genet,2001,10(7 ):721-733.
  • 7Cormier RT, Hong KH, Halberg RB, et al. Secretory phospholipase Pla2g2a confersresistance to intestinal tumorigenesis [ J ]. Nature Genet, 1997,17 ( 1 ): 88-91.
  • 8Cormier RT, Dove WF. Dnmt 1 N/+ reduces the net growth rate and multiplicity ofintestinal adenomas in C57BL/6-multiple intestinal neoplasia ( min)/+ mice independentlyof p53 but demonstrates strong synergy with the modifier of min 1 ( AKR )resistance allele[ J ]. Cancer Res,2000,60 ( 14 ): 3965-3970.
  • 9Halberg RH, Katzung DS, Hoff PD, et al. Tumorigengsis in the multiple intestinalneoplasia mouse: redundancy of negative regulators and specificity of modifiers [ J ].Proc Natl Acad Sci USA, 2000,28 ( 7 ): 3461-3466.
  • 10Silverman KA, Koratkar R, Siracusa LD, et al. Identification of the modifier ofMin 2 (Mom) locus, a new mutation that influences Apc-induced intestinal neoplasia [ J ].Genone Res,2002,12( 1 ) :88-97.

同被引文献62

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部